New prostate cancer drug rolls out to thousands, but charity warns of postcode lottery

iStock.com/ William DondyK

By Lily Canter

A prostate cancer drug that can halve death risk is to be offered to thousands of men in England.

The National Institute for Health and Care (NICE) has given the green light to darolutamide, an oral alternative to chemotherapy with fewer side-effects.